HIV and the new viruses

LDR 03082nam a22004694a 4500
001 004032713
003 MiAaHDL
005 20210817000000.0
006 m d
007 cr bn ---auaua
008 990823s1999 caua b 001 0 eng
010 ⊔ ⊔ ‡a98083211
015 ⊔ ⊔ ‡aGB99-Y8155
020 ⊔ ⊔ ‡a0122007417 ‡q(alk. paper)
035 ⊔ ⊔ ‡a(MiU)990040327130106381
035 ⊔ ⊔ ‡asdr-miu.990040327130106381
035 ⊔ ⊔ ‡a(III)iiio31950139
035 ⊔ ⊔ ‡a(OCoLC)40927183
035 ⊔ ⊔ ‡z(MiU)Aleph004032713
040 ⊔ ⊔ ‡aDLC ‡cDLC ‡dUKM ‡dCOU ‡dVAM ‡dEYM
042 ⊔ ⊔ ‡apcc
050 0 0 ‡aQR201.A37 ‡bA36 1999
082 0 0 ‡a616.97/92 ‡221
096 ⊔ ⊔ ‡aWC 500 ‡bH676 1999
130 0 ⊔ ‡aAIDS and the new viruses.
245 1 0 ‡aHIV and the new viruses / ‡c[edited by] Angus Dalgleish and Robin Weiss.
250 ⊔ ⊔ ‡a2nd ed
260 ⊔ ⊔ ‡aSan Diego, Calif. : ‡bAcademic, ‡cc1999.
300 ⊔ ⊔ ‡aix, 554 p. : ‡bill. ; ‡c26 cm.
500 ⊔ ⊔ ‡aPrevious ed.: published as AIDS and the new viruses. 1990.
504 ⊔ ⊔ ‡aIncludes bibliographical references and index.
505 0 ⊔ ‡aCh. 20. Hepatitis B and delta viruses-- Ch. 21. Hepatitis C and G viruses- old or new?-- Ch. 22. Endogenous retroviruses-- Ch. 23. New viruses and diseases of the human central nervous system-- Ch. 24. Emerging viruses: their diseases and identification.
505 0 ⊔ ‡aCh. 14. HIV resistance to antagonists of viral reverse transcriptase-- Ch. 15. Non-lentiviral primate retroviruses-- Ch. 16. Genetic diversity and molecular epidemiology of primate T cell lymphotrophic viruses: human T cell leukaemia/lymphoma viruses types 1 and 2 and related simian retroviruses (STLV-1, STLV-2 pan-p and PTLV-L)-- Ch. 17. Human herpesvirus 6-- Ch. 18. Kaposi's sarcoma and human herpesvirus 8-- Ch. 19. Pathogenesis and cell biology of Kaposi's sarcoma
505 0 ⊔ ‡aCh. 7. Molecular control of programmed cell death in HIV infection: contribution to the dysregulation of T cell homeostasis and to CD4 T cell depletion-- Ch. 8. The relationships between cytokines, complement and HIV infection-- Ch. 9. Chemokine receptors and HIV-1 pathogenesis: a viral fatal attraction-- Ch. 10. HLA and HIV-1 infection-- Ch. 11. The potential role of HLA mimicry in the pathogenesis of AIDS-- Ch. 12. The impact of antiviral therapy on HIV disease-- Ch. 13. HIV-1 and HIV-2 molecular diagnosis
505 0 ⊔ ‡aCh. 1. HIV-1: control of gene expression by the viral regulatory proteins Tat and Rev-- Ch. 2. Viral evolution and variation in the HIV pandemic-- Ch. 3. Biological properties of HIV-1 and their relevance for AIDS pathogenesis-- Ch. 4. HIV dynamics: lessons from the use of antiretrovirals-- Ch. 5. The cytotoxic T lymphocyte response to the immunodeficiency viruses-- Ch. 6. T helper cells specific for retroviral epitopes
538 ⊔ ⊔ ‡aMode of access: Internet.
650 ⊔ 2 ‡aHepatitis Viruses ‡xpathogenicity
650 ⊔ 2 ‡aHerpesviridae ‡xpathogenicity
650 ⊔ 2 ‡aHTLV-BLV ‡xpathogenicity
650 ⊔ 2 ‡aHIV-1 ‡xpathogenicity
650 ⊔ 2 ‡aHIV Infections
650 ⊔ 0 ‡aHepatitis viruses.
650 ⊔ 0 ‡aHepatitis, Viral.
650 ⊔ 0 ‡aHerpesvirus diseases.
650 ⊔ 0 ‡aHIV infections.
700 1 ⊔ ‡aWeiss, Robin.
700 1 ⊔ ‡aDalgleish, A. G. ‡q(Angus G.)
CID ⊔ ⊔ ‡a004032713
DAT 0 ⊔ ‡a19990823000000.0 ‡b20210817000000.0
DAT 1 ⊔ ‡a20210819090747.0 ‡b2021-08-20T14:18:15Z
DAT 2 ⊔ ‡a2009-01-14T00:30:50Z
CAT ⊔ ⊔ ‡aSDR-MIU ‡dALMA ‡lprepare.pl-004-008
FMT ⊔ ⊔ ‡aBK
HOL ⊔ ⊔ ‡0sdr-miu.990040327130106381 ‡aMiU ‡bSDR ‡cMIU ‡pmdp.39015043779092 ‡sMIU ‡1990040327130106381
974 ⊔ ⊔ ‡bMIU ‡cMIU ‡d20210820 ‡sgoogle ‡umdp.39015043779092 ‡y1999 ‡ric ‡qbib ‡tUS bib date1 >= 1929